Co-Authors
This is a "connection" page, showing publications co-authored by Dimitrios Patoulias and Michael Doumas.
Connection Strength
10.061
-
Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies. Endocrinol Metab (Seoul). 2021 08; 36(4):904-908.
Score: 0.959
-
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Kardiol Pol. 2021; 79(9):1048-1049.
Score: 0.958
-
Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic. Diabetes Obes Metab. 2021 Jul; 23(7):1696-1700.
Score: 0.934
-
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend? Pol Arch Intern Med. 2020 10 29; 130(10):922.
Score: 0.911
-
Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions. Diabetes Ther. 2020 Dec; 11(12):3003-3005.
Score: 0.908
-
Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities. Curr Hypertens Rep. 2020 09 10; 22(11):90.
Score: 0.902
-
Diabetes mellitus and SARS-CoV-2-related mortality: the impact of acute hyperglycemic crises and some further considerations. Acta Diabetol. 2021 01; 58(1):125-126.
Score: 0.898
-
Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Pol Arch Intern Med. 2019 09 30; 129(9):648-649.
Score: 0.845
-
Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly. Pol Arch Intern Med. 2019 Feb 28; 129(2):143-144.
Score: 0.811
-
SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature. Curr Clin Pharmacol. 2018; 13(4):261-272.
Score: 0.749
-
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials. Clin Rheumatol. 2021 Nov; 40(11):4671-4674.
Score: 0.241
-
COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute? J Hum Hypertens. 2020 11; 34(11):764-767.
Score: 0.223
-
COVID-19: The Waterloo of governments, healthcare systems, and large health organizations. Eur J Intern Med. 2020 Jul; 77:153-155.
Score: 0.221
-
Right Ventricular Function and Sexual Function: Exploring Shadows in Male and Female Patients With Heart Failure. J Sex Med. 2019 08; 16(8):1199-1211.
Score: 0.206
-
Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation. Curr Pharm Des. 2018; 24(31):3638-3646.
Score: 0.187
-
Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review. SN Compr Clin Med. 2020; 2(9):1419-1429.
Score: 0.056
-
Evaluation, risk stratification and management of hypertensive patients in the perioperative period. Eur J Intern Med. 2019 Nov; 69:1-7.
Score: 0.053